22 Jan 2013, BioSpectrum Bureau , BioSpectrum
Singapore: US-based Stratasys, a leading manufacturer of 3D printers and production systems for prototyping and manufacturing, has appointed Medicodi and PD Dental as new channel partners in Korea.
The new partners will focus on the distribution of Stratasys' award-winning 3D printing technology to the dental market. This appointment marks the increasing demand for 3D printing and the large potential for digital dentistry in Korea. By combining Stratasys' 3D printing technology with Medicodi and PD Dental's expertise and experience in the field.
"Over the past few years, we have provided industry-driven 3D printing solutions to support the growth and advancement of digital dentistry in Korea and around the world," said Mr Gilad Gans, executive VP, global field operations, Stratasys. "Korea is a strategic market in Asia Pacific, and we are confident that these local partnerships will help address the unique needs of the country's dental industry."
3D printing is at the heart of the new digital era in dentistry. Combined with intra-oral scanning, CAD/CAM and design software, 3D printing helps dental labs produce a range of orthodontic appliances such as dental stone models, clear aligners and true-to-life veneer prototypes accurately and rapidly.
Mr Sun-Kyu Choi, CEO, Medicodi, "We are a strong believer in Stratasys' cutting edge 3D printing technology and the value it brings to the dental industry. With Stratasys, we will play a critical role to provide professional 3D printing solutions to dental labs and clinics, maximizing our customers' competitiveness and effectiveness."